Cargando…
Trait anxiety is related to Nx4’s efficacy on stress-induced changes in amygdala-centered resting state functional connectivity: a placebo-controlled cross-over trial in mildly to moderately stressed healthy volunteers
BACKGROUND: The multicomponent drug Neurexan (Nx4) was shown to reduce the neural stress network activation. We now investigated its effects on stress-induced resting state functional connectivity (RSFC) in dependence of trait anxiety (TA), an acknowledged vulnerability factor for stress-induced psy...
Autores principales: | Nanni-Zepeda, Melanni, Alizadeh, Sarah, Chand, Tara, Kasties, Vanessa, Fan, Yan, van der Meer, Johan, Herrmann, Luisa, Vester, Johannes C., Schulz, Myron, Naschold, Britta, Walter, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694608/ https://www.ncbi.nlm.nih.gov/pubmed/36434512 http://dx.doi.org/10.1186/s12868-022-00754-4 |
Ejemplares similares
-
Correction: Trait anxiety is related to Nx4’s efficacy on stress-induced changes in amygdala-centered resting state functional connectivity: a placebo-controlled cross-over trial in mildly to moderately stressed healthy volunteers
por: Nanni-Zepeda, Melanni, et al.
Publicado: (2023) -
Nx4 Modulated Resting-State Functional Connectivity Between Amygdala and Prefrontal Cortex in a Placebo-Controlled, Crossover Trial
por: Chand, Tara, et al.
Publicado: (2022) -
fMRI Revealed Reduced Amygdala Activation after Nx4 in Mildly to Moderately Stressed Healthy Volunteers in a Randomized, Placebo-Controlled, Cross-Over Trial
por: Herrmann, Luisa, et al.
Publicado: (2020) -
Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task
por: Mayer, Kathrin, et al.
Publicado: (2021) -
EEG revealed improved vigilance regulation after stress exposure under Nx4 – A randomized, placebo-controlled, double-blind, cross-over trial
por: Chand, Tara, et al.
Publicado: (2021)